Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers

0
0 / 5 (0 votos)

Alimentary Pharmacology & Therapeutics

Fecha de publicación: 31 january 2019

DOI: https://doi.org/10.1111/apt.15141

Autores: Ammar Hassanzadeh Keshteli, Karen L. Madsen, Rupasri Mandal, Guy E. Boeckxstaens, Premysl Bercik, Giada De Palma, David E. Reed, David Wishart, Stephen Vanner, Levinus A. Dieleman.

Background: Evaluation of the metabolomic profile of patients with irritable bowel syndrome offers an opportunity to identify novel pathophysiological targets and biomarkers that could discriminate this disorder from related conditions.

Seguir leyendo